Stock Scorer

Acadia Healthcare Company, Inc. (ACHC) · Insider trading

What Acadia Healthcare's directors, officers and largest holders bought and sold themselves, from the Form 4 each of them files with the SEC within two business days of a trade. Open-market purchases and sales first: those are the trades somebody chose to make at the market price.

Bought, 12 months
$0
0 insiders, 0 trades
Sold, 12 months
$0
0 insiders
Net, 12 months
$0
bought less sold
Latest filing
2026-07-27
filings read to 2026-10-19

Bought and sold at the market, by month

Two years. Purchases above the line, sales below, in dollars.

2025-01 2025-07 2026-01 2026-07
Bought Sold Largest month: $0

No director, officer or large holder of Acadia Healthcare reported buying or selling at the market price in the last two years. What they did report is below.

Grants, exercises and other transactions

Pay, tax and paperwork rather than a choice to trade at the market price. Two years.

39 × grant or award15 × shares withheld for tax
Show them
DateInsiderWhatShares PriceHolds afterFiling
2026-07-26 Farley BrianEVP, CLAO and Secretary Shares withheld for tax F −1,770 34.51 135,982 Form 4
2026-06-26 Farley BrianEVP, CLAO and Secretary Shares withheld for tax F −1,370 26.24 137,752 Form 4
2026-05-06 Bissell E. PerotDirector Grant or award A +6,331 – 51,986 Form 4
2026-05-06 Bissell E. PerotDirector Grant or award A +5,500 – 57,486 Form 4
2026-05-06 Waud Reeve BDirector Grant or award A +6,331 – 66,283 Form 4
2026-05-06 Waud Reeve BDirector Grant or award A +9,576 – 75,859 Form 4
2026-05-06 Harris Patrice ADirector Grant or award A +6,331 – 17,914 Form 4
2026-05-06 Cancelmi Daniel JDirector Grant or award A +6,331 – 12,956 Form 4
2026-05-06 Grieco WilliamDirector Grant or award A +6,331 – 96,212 Form 4
2026-05-06 Bernhard JasonDirector Grant or award A +6,331 – 40,235 Form 4
2026-05-06 Bernhard JasonDirector Grant or award A +5,124 – 45,359 Form 4
2026-05-06 Gregg Vicky BDirector Grant or award A +6,331 – 42,628 Form 4
2026-05-06 Kelly Ralph DavidDirector Grant or award A +6,331 – 26,358 Form 4
2026-05-06 Fucci MichaelDirector Grant or award A +6,331 – 28,152 Form 4
2026-05-05 Farley BrianEVP, CLAO and Secretary Shares withheld for tax F −5,063 27.69 139,122 Form 4
2026-04-28 Farley BrianEVP, CLAO and Secretary Grant or award A +37,510 – 144,185 Form 4
2026-04-10 Farley BrianEVP, GC and Secretary Grant or award A +37,510 – 106,675 Form 4
2026-04-10 Young Todd S.Chief Financial Officer Grant or award A +58,799 – 107,244 Form 4
2026-03-12 Cancelmi Daniel JDirector Grant or award A +6,625 – 6,625 Form 4
2026-02-27 Farley BrianEVP, GC and Secretary Shares withheld for tax F −1,915 22.29 69,165 Form 4
2025-10-27 Young Todd S.Chief Financial Officer Grant or award A +48,445 – 48,445 Form 4
2025-09-30 Khan NasserChief Operating Officer Shares withheld for tax F −973 24.54 55,023 Form 4
2025-07-26 Farley BrianEVP, GC and Secretary Shares withheld for tax F −1,095 22.26 71,080 Form 4
2025-07-25 Dixon Heather BrianneChief Financial Officer Shares withheld for tax F −2,410 21.74 118,581 Form 4
2025-06-26 Farley BrianEVP, GC and Secretary Shares withheld for tax F −847 20.94 72,175 Form 4
2025-06-26 Dixon Heather BrianneChief Financial Officer Shares withheld for tax F −1,508 20.94 120,991 Form 4
2025-06-26 Hunter Christopher H.Director, Chief Executive Officer Shares withheld for tax F −5,464 20.94 258,530 Form 4
2025-05-29 Harris Patrice ADirector Grant or award A +7,032 – 11,583 Form 4
2025-05-29 Bernhard JasonDirector Grant or award A +7,032 – 29,421 Form 4
2025-05-29 Bernhard JasonDirector Grant or award A +4,483 – 33,904 Form 4
2025-05-29 Kelly Ralph DavidDirector Grant or award A +7,032 – 15,104 Form 4
2025-05-29 Kelly Ralph DavidDirector Grant or award A +4,923 – 20,027 Form 4
2025-05-29 Fucci MichaelDirector Grant or award A +7,032 – 21,821 Form 4
2025-05-29 Waud Reeve BDirector Grant or award A +7,032 – 49,315 Form 4
2025-05-29 Waud Reeve BDirector Grant or award A +10,637 – 59,952 Form 4
2025-05-29 Grieco WilliamDirector Grant or award A +7,032 – 85,486 Form 4
2025-05-29 Grieco WilliamDirector Grant or award A +4,395 – 89,881 Form 4
2025-05-29 Gregg Vicky BDirector Grant or award A +7,032 – 36,297 Form 4
2025-05-29 Miquelon Wade DDirector Grant or award A +7,032 – 55,520 Form 4
2025-05-29 Bissell E. PerotDirector Grant or award A +7,032 – 45,655 Form 4
2025-05-09 Hunter Christopher H.Director, Chief Executive Officer Shares withheld for tax F −1,889 24.22 263,994 Form 4
2025-05-05 Hunter Christopher H.Director, Chief Executive Officer Grant or award A +115,818 – 247,102 Form 4
2025-05-05 Hunter Christopher H.Director, Chief Executive Officer Grant or award A +18,781 – 265,883 Form 4
2025-05-05 Khan NasserChief Operating Officer Grant or award A +30,676 – 55,996 Form 4
2025-05-05 Farley BrianEVP, GC and Secretary Grant or award A +38,606 – 73,022 Form 4
2025-05-05 Dixon Heather BrianneChief Financial Officer Grant or award A +43,823 – 122,499 Form 4
2025-04-11 Hunter Christopher H.Director, Chief Executive Officer Shares withheld for tax F −1,477 27.08 131,284 Form 4
2025-03-01 Khan NasserChief Operating Officer Shares withheld for tax F −226 29.98 25,320 Form 4
2025-02-27 Hunter Christopher H.Director, Chief Executive Officer Grant or award A +6,672 – 136,632 Form 4
2025-02-27 Hunter Christopher H.Director, Chief Executive Officer Grant or award A +13,124 – 149,756 Form 4
2025-02-27 Hunter Christopher H.Director, Chief Executive Officer Shares withheld for tax F −16,995 40.26 132,761 Form 4
2025-02-27 Farley BrianEVP, GC and Secretary Grant or award A +2,530 – 34,416 Form 4
2025-02-27 Dixon Heather BrianneChief Financial Officer Grant or award A +11,659 – 78,676 Form 4
2024-11-07 Khan NasserChief Operating Officer Shares withheld for tax F −405 42.49 25,546 Form 4

How to read it

Buy, sale
Code P and S on the form: shares bought or sold in the market, at the market price. The other codes are mostly pay (a grant, an option exercised) or tax (shares the company withheld), and say little about what the insider thinks of the price.
Plan
A sale or purchase under a Rule 10b5-1 plan, set up in advance and running on its own schedule. Since April 2023 the form has a box for it. Much executive selling is planned and says more about diversifying than about the company.
Holds after
The shares the insider still held after the trade, in the form the trade was in (directly, or indirectly through a trust or a fund).
Value
Shares times the price the form reports, which is often an average over several fills on the day.

Read from the SEC's own quarterly data sets of Forms 3, 4 and 5, and from each day's filings since the last one. A correcting amendment replaces the lines it restates. Every row links to its filing. None of this is advice: insiders sell for many reasons, and buy for fewer.

Acadia Healthcare's scores and multiples ›